Evidence map›Paper›PMID 32432108›Full record

ArticleFrontiers in cell and developmental biology2020

Dendritic Spine and Synaptic Plasticity in Alzheimer's Disease: A Focus on MicroRNA.

Edwin Estefan Reza-Zaldivar, Mercedes Azucena Hernández-Sápiens, Benito Minjarez, Ulises Gómez-Pinedo, Victor Javier Sánchez-González, Ana Laura Márquez-Aguirre, Alejandro Arturo Canales-Aguirre

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Effects ofFrontiers in pharmacology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Deletion ofInternational journal of molecular sciences · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Edwin Estefan Reza-ZaldivarMedical and Pharmaceutical Biotechnology Unit, CIATEJ, Guadalajara, Mexico.
Mercedes Azucena Hernández-SápiensMedical and Pharmaceutical Biotechnology Unit, CIATEJ, Guadalajara, Mexico.
Benito MinjarezUniversity Center of Biological and Agricultural Sciences, University of Guadalajara, Guadalajara, Mexico.
Ulises Gómez-PinedoInstitute of Neurosciences, IdISSC, San Carlos Clinical Hospital, Madrid, Spain.
Victor Javier Sánchez-GonzálezUniversity Center of Los Altos, University of Guadalajara, Guadalajara, Mexico.
Ana Laura Márquez-AguirreMedical and Pharmaceutical Biotechnology Unit, CIATEJ, Guadalajara, Mexico.
Alejandro Arturo Canales-AguirreMedical and Pharmaceutical Biotechnology Unit, CIATEJ, Guadalajara, Mexico.
Universidad de Guadalajara · MXInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dendrites and dendritic spines are dynamic structures with pivotal roles in brain connectivity and have been recognized as the locus of long-term synaptic plasticity related to cognitive processes such as learning and memory. In neurodegenerative diseases, the spine dynamic morphology alteration, such as shape and spine density, affects functional characteristics leading to synaptic dysfunction and cognitive impairment. Recent evidence implicates dendritic spine dysfunction as a critical feature in the pathogenesis of dementia, particularly Alzheimer's disease. The alteration of spine morphology and their loss is correlated with the cognitive decline in Alzheimer's disease patients even in the absence of neuronal loss, however, the underlying mechanisms are poorly understood. Currently, the microRNAs have emerged as essential regulators of synaptic plasticity. The changes in neuronal microRNA expression that contribute to the modification of synaptic function through the modulation of dendritic spine morphology or by regulating the local protein translation to synaptic transmission are determinant for synapse formation and synaptic plasticity. Focusing on microRNA and its targets may provide insight into new therapeutic opportunities. In this review we summarize the experimental evidence of the role that the microRNA plays in dendritic spine remodeling and synaptic plasticity and its potential therapeutic approach in Alzheimer's disease. Targeting synaptic deficits through the structural alteration of dendritic spines could form part of therapeutic strategies to improve synaptic plasticity and to ameliorate cognitive impairments in Alzheimer's disease and other neurological diseases.

Indexed as

Alzheimer’s diseasedendritic spinemicroRNAspine remodelingsynaptic plasticity

Identifiers

PMID32432108
PMCPMC7214692
OpenAlexW3023152385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.